ORBIMED ADVISORS LLC – KalVista Pharmaceuticals, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$15.11M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
+47.46%
quarter
KalVista Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +462.03% | 856.6K shares | 13.29M | $14.51 | 1.04M |
| Q2 2022 | share | Increase | 0.00% | 185.4K shares | 1.82M | $9.84 | 185.4K |
| Q2 2020 | share | Decrease | -100.00% | -420.64K shares | -3.21M | $12.1 | 0 |
| Q1 2020 | share | Increase | +162.01% | 260.1K shares | 359K | $7.65 | 420.64K |
| Q4 2019 | share | Increase | +314.48% | 121.80K shares | 2.41M | $17.81 | 160.54K |
| Q3 2019 | share | Increase | 0.00% | 38.73K shares | 449K | $11.6 | 38.73K |
| Q2 2019 | share | Decrease | -100.00% | -90.5K shares | -2.59M | $22.15 | 0 |
| Q1 2019 | share | Increase | 0.00% | 90.5K shares | 2.59M | $28.62 | 90.5K |